<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>St John's Wort: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i905.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i905.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i905.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i229.htm">Antidepressants</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i262.htm" title="Previous: Moclobemide">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i263.htm" title="Next: Tryptophan">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i905">St John's Wort</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>St John's Wort</b>
          has the following interaction information:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody><tr><td><a href="41001i572.htm" name="_572">5HT<sub>1</sub>-receptor Agonists</a></td><td class="cBV"><b>increased serotonergic effects when  St John's wort given with 5HT<sub>1</sub> agonists—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i242.htm" name="_242">Amitriptyline</a></td><td> St John's wort reduces plasma concentration of amitriptyline </td><td></td></tr><tr><td><a href="41001i470.htm" name="_470">Amlodipine</a></td><td> St John's wort possibly reduces plasma concentration of amlodipine </td><td></td></tr><tr><td><a href="41001i232.htm" name="_232">Antidepressants, SSRI</a></td><td class="cBV"><b>increased serotonergic effects when  St John's wort given with SSRIs—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i276.htm">Antiepileptics</a></td><td class="cBV"><b>avoid concomitant use of  St John's wort with antiepileptics </b></td><td></td></tr><tr><td><a href="41001i1010.htm" name="_1010">Aprepitant</a></td><td class="cBV"><b>avoidance of  St John's wort advised by manufacturer of aprepitant </b></td><td></td></tr><tr><td><a href="41001i1011.htm" name="_1011">Aripiprazole</a></td><td class="cBV"><b> St John's wort possibly reduces plasma concentration of aripiprazole—increase dose of aripiprazole</b></td><td></td></tr><tr><td><a href="41001i1005.htm" name="_1005">Atazanavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of atazanavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1204.htm" name="_1204">Cabazitaxel</a></td><td class="cBV"><b>avoidance of  St John's wort advised by manufacturer of cabazitaxel </b></td><td></td></tr><tr><td><a href="41001i499.htm" name="_499">Ciclosporin</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of ciclosporin—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i220.htm" name="_220">Coumarins</a></td><td class="cBV"><b> St John's wort reduces anticoagulant effect of coumarins (avoid concomitant use)</b></td><td>Change in patient’s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</td></tr><tr><td><a href="41001i1120.htm" name="_1120">Dabigatran Etexilate</a></td><td> St John's wort possibly reduces plasma concentration of dabigatran etexilate—manufacturer of dabigatran etexilate advises avoid concomitant use</td><td></td></tr><tr><td><a href="41001i1091.htm" name="_1091">Darunavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of darunavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i480.htm" name="_480">Digoxin</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of digoxin—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1176.htm" name="_1176">Dronedarone</a></td><td class="cBV"><b> St John's wort possibly reduces plasma concentration of dronedarone—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1024.htm">Duloxetine</a></td><td>possible increased serotonergic effects when  St John's wort given with duloxetine </td><td></td></tr><tr><td><a href="41001i874.htm" name="_874">Efavirenz</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of efavirenz—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1025.htm" name="_1025">Eplerenone</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of eplerenone—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1205.htm" name="_1205">Eribulin</a></td><td> St John's wort possibly reduces plasma concentration of eribulin </td><td></td></tr><tr><td><a href="41001i1135.htm" name="_1135">Etravirine</a></td><td>avoidance of  St John's wort advised by manufacturer of etravirine </td><td></td></tr><tr><td><a href="41001i1169.htm" name="_1169">Everolimus</a></td><td> St John's wort possibly reduces plasma concentration of everolimus—manufacturer of everolimus advises avoid concomitant use</td><td></td></tr><tr><td><a href="41001i1019.htm" name="_1019">Fosamprenavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of fosamprenavir—avoid concomitant use</b></td><td>Fosamprenavir is a prodrug of amprenavir</td></tr><tr><td><a href="41001i1170.htm" name="_1170">Gefitinib</a></td><td>avoidance of  St John's wort advised by manufacturer of gefitinib </td><td></td></tr><tr><td><a href="41001i933.htm" name="_933">Imatinib</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of imatinib—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i398.htm" name="_398">Indinavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of indinavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1006.htm" name="_1006">Irinotecan</a></td><td class="cBV"><b> St John's wort accelerates metabolism of irinotecan (reduced plasma  concentration—avoid concomitant use)</b></td><td></td></tr><tr><td><a href="41001i1050.htm" name="_1050">Ivabradine</a></td><td> St John's wort reduces plasma concentration of ivabradine—avoid concomitant use</td><td></td></tr><tr><td><a href="41001i1128.htm" name="_1128">Lapatinib</a></td><td class="cBV"><b>avoidance of  St John's wort advised by manufacturer of lapatinib </b></td><td></td></tr><tr><td><a href="41001i922.htm" name="_922">Lopinavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of lopinavir—avoid concomitant use</b></td><td>In combination with ritonavir as <i>Kaletra</i>® (ritonavir is present to inhibit lopinavir metabolism and increase plasma-lopinavir concentration)—see also Ritonavir</td></tr><tr><td><a href="41001i1107.htm" name="_1107">Maraviroc</a></td><td class="cBV"><b> St John's wort possibly reduces plasma concentration of maraviroc—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i97.htm" name="_97">Methadone</a></td><td> St John's wort possibly reduces plasma concentration of methadone </td><td></td></tr><tr><td><a href="41001i421.htm" name="_421">Midazolam</a></td><td> St John's wort possibly reduces plasma concentration of <i>oral</i> midazolam </td><td></td></tr><tr><td><a href="41001i842.htm" name="_842">Nelfinavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of nelfinavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i843.htm" name="_843">Nevirapine</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of nevirapine—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i475.htm" name="_475">Nifedipine</a></td><td> St John's wort reduces plasma concentration of nifedipine </td><td></td></tr><tr><td><a href="41001i636.htm" name="_636">Oestrogens</a></td><td class="cBV"><b> St John's wort reduces contraceptive effect of oestrogens (avoid concomitant use)</b></td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="4552.htm#_120026">section 7.3.1</a></td></tr><tr><td><a href="41001i752.htm" name="_752">Omeprazole</a></td><td> St John's wort possibly reduces plasma concentration of omeprazole </td><td></td></tr><tr><td><a href="41001i664.htm" name="_664">Progestogens</a></td><td class="cBV"><b> St John's wort reduces contraceptive effect of progestogens (avoid concomitant use)</b></td><td>Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="" href="4552.htm#_120026">section 7.3.1</a>. For further information on interactions of oral progestogen-only contraceptives, see also <a title="" href="4572.htm#_4572.2">section 7.3.2.1</a>; parenteral progestogen-only contraceptives, see also <a title="" href="4580.htm#_4580.4">section 7.3.2.2</a>; the intra-uterine progestogen-only device, see also <a title="" href="31947.htm#_31947.1">section 7.3.2.3</a>; hormonal emergency contraception, see also <a title="" href="130057.htm#_100043.3">section 7.3.5</a></td></tr><tr><td><a href="41001i400.htm" name="_400">Ritonavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of ritonavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i791.htm" name="_791">Saquinavir</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of saquinavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i605.htm" name="_605">Simvastatin</a></td><td> St John's wort reduces plasma concentration of simvastatin </td><td></td></tr><tr><td><a href="41001i730.htm" name="_730">Tacrolimus</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of tacrolimus—avoid concomitant use</b></td><td>Interactions do not generally apply to tacrolimus used topically; risk of facial flushing and skin irritation with alcohol consumption (<a title="monograph: TACROLIMUS" href="119635.htm#_119635">see section 13.5.3</a>) does not apply to tacrolimus taken systemically</td></tr><tr><td><a href="41001i1216.htm" name="_1216">Telaprevir</a></td><td class="cBV"><b>avoidance of  St John's wort advised by manufacturer of telaprevir </b></td><td></td></tr><tr><td><a href="41001i946.htm">Telithromycin</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of telithromycin (avoid during and for 2 weeks after St John's wort)</b></td><td></td></tr><tr><td><a href="41001i734.htm" name="_734">Theophylline</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of theophylline—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1055.htm" name="_1055">Tipranavir</a></td><td class="cBV"><b> St John's wort possibly reduces plasma concentration of tipranavir—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1163.htm" name="_1163">Ulipristal</a></td><td class="cBV"><b>avoidance of  St John's wort advised by manufacturer of ulipristal (contraceptive effect of ulipristal possibly reduced)</b></td><td></td></tr><tr><td><a href="41001i240.htm" name="_240">Venlafaxine</a></td><td>possible increased serotonergic effects when  St John's wort given with venlafaxine </td><td></td></tr><tr><td><a href="41001i467.htm" name="_467">Verapamil</a></td><td class="cBV"><b> St John's wort significantly reduces plasma concentration of verapamil </b></td><td></td></tr><tr><td><a href="41001i1181.htm" name="_1181">Vinflunine</a></td><td class="cBV"><b> St John's wort possibly reduces plasma concentration of vinflunine—manufacturer of vinflunine advises avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i948.htm" name="_948">Voriconazole</a></td><td class="cBV"><b> St John's wort reduces plasma concentration of voriconazole—avoid concomitant use</b></td><td></td></tr></tbody></table><p>St John's Wort belongs to <b>Antidepressants</b>
          and will have the following interactions:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>


<tr><td><a href="41001i937.htm">Artemether with Lumefantrine</a></td><td class="cBV"><b>avoidance of  antidepressants advised by manufacturer of artemether/lumefantrine </b></td><td></td></tr><tr><td><a href="41001i1009.htm">Atomoxetine</a></td><td>possible increased risk of convulsions when  antidepressants given with atomoxetine </td><td></td></tr></tbody></table></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i262.htm">Previous: Moclobemide</a> | <a class="top" href="41001i905.htm#">Top</a> | <a accesskey="]" href="41001i263.htm">Next: Tryptophan</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>